ID   FL 62891
AC   CVCL_6390
SY   FL62891
DR   CLO; CLO_0003359
DR   ATCC; CRL-11005
DR   BioSample; SAMN03471327
DR   Wikidata; Q54834950
RX   Patent=US5621090;
RX   Patent=US5912133;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11005.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [Note=tsA58].
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
//
RX   Patent=US5621090;
RA   Lemischka I.R.;
RT   "Nucleic acids encoding soluble human FLK-2 extracellular domain.";
RL   Patent number US5621090, 15-Apr-1997.
//
RX   Patent=US5912133;
RA   Lemischka I.R.;
RT   "Method for isolating stem cells expressing flk-1 receptors.";
RL   Patent number US5912133, 15-Jun-1999.
//